Erector Spinae Plane Block for Children Undergoing Thoracoscopic Sympathectomy

NCT ID: NCT06984874

Last Updated: 2025-05-22

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

40 participants

Study Classification

INTERVENTIONAL

Study Start Date

2025-01-15

Study Completion Date

2025-12-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study aims to evaluate the influence of ultrasound-guided erector spinae plane block on postoperative pain and diaphragmatic dysfunction in pediatric patients undergoing thoracoscopic sympathectomy.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Pain may occur after pediatric thoracic surgery in cases such as skin incision creation, rib traction, and drain placement, and in other cases, such as rib nerve injury. Such pain is highly unfavorable to pediatric patients' recovery as it may lead to reduced cough strength for clearing secretions, decreased functional residual capacity, and pulmonary complications such as atelectasis and pneumonia.

Erector spinae plane block (ESPB) is a novel trunk block to relieve chronic neuropathic pain. Since then, it has gained prominence as a regional anesthesia technique with the potential to revolutionize postoperative pain management, and it has been effectively administered not only for the management of perioperative pain for a wide variety of surgeries but also for the management of acute post-traumatic pain and chronic pain.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Erector Spinae Plane Block Children Thoracoscopic Sympathectomy

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

DOUBLE

Participants Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Erector spinae plane block group

Patients will receive bilateral erector spinae plane block after the induction of general anesthesia as a study group.

Group Type EXPERIMENTAL

Erector spinae plane block

Intervention Type OTHER

Patients will receive bilateral erector spinae plane block after the induction of general anesthesia as a study group.

Control group

Patients will not receive the block after the induction of general anesthesia as a control group.

Group Type ACTIVE_COMPARATOR

General anesthesia

Intervention Type OTHER

Patients will not receive the block after the induction of general anesthesia as a control group.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Erector spinae plane block

Patients will receive bilateral erector spinae plane block after the induction of general anesthesia as a study group.

Intervention Type OTHER

General anesthesia

Patients will not receive the block after the induction of general anesthesia as a control group.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age from 6 to 16 years.
* Either sexes (male or female).
* American Society of Anesthesiologists (ASA) physical status I-II.
* Scheduled for bilateral thoracoscopic sympathectomy under general anesthesia.

Exclusion Criteria

* History of allergy to local anesthetics.
* Abnormal liver/kidney function.
* Severe spinal deformities.
* Bleeding or coagulation disorders.
* Skin damage or infection at the proposed puncture site.
Minimum Eligible Age

6 Years

Maximum Eligible Age

16 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Menoufia University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

SAFAA MOHAMED SALLAM

Assistant Lecturer of Anesthesiology, Intensive Care and Pain Medicine, Faculty of Medicine, Menoufia University, Egypt.

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Menoufia University

Shibīn al Kawm, Menoufia, Egypt

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Egypt

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Safaa M Sallam, Master

Role: CONTACT

00201001876902

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Safaa M Sallam, Master

Role: primary

00201001876902

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

1/2025

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.